Full-Time

IT Support Analyst

Posted on 9/13/2025

Cencora

Cencora

10,001+ employees

Global pharmaceutical distribution and services provider

Compensation Overview

€3.1k - €5.1k/mo

London, UK + 1 more

More locations: Remote in Germany

Remote

Candidates will be expected to work either EMEA business hours.

Category
IT & Security
Required Skills
ServiceNow
SAP Products
Requirements
  • Significant proven application support experience in a complex, highly integrated environment is highly desired
  • Strong experience with problem/incident management, including ticket creation, management and escalation to resolution is highly desired; experience with ServiceNow is a plus
  • Experience in supporting an international solution for a global company is strongly preferred
  • Experience working with a Transportation Management System (TMS) or within a logistics environment is a plus; experience with MercuryGate TMS is preferred
  • Experience with technical tasks such as researching C-IMP (Airline messaging such as FHL, FSU, etc), XML, JSON, and others is a plus
  • Four-year degree or greater with equivalent experience will be considered
  • Existing World Courier Business unit experience is also a plus (Customer Service, Operations, Finance)
Responsibilities
  • Participates in (and where possible, streamlines) the support process by providing Level 2 support (and greater where needed), triaging support tickets, managing and analyzing issues, and recommending fixes and solutions to enhance the quality of our products and services to our customers across all NOVA Manages Transportation Products; ex: DASH/Mobility, JetStream, OMNI, TMS, SAP, etc.
  • Provide support to customer’s request (customer for this role refers to internal business unit colleagues and not actual World Courier revenue generating customers)
  • Identifies trends from support tickets and makes recommendations for continual improvements to products, processes, and training
  • Acts as liaison with internal/external technical teams, consultants and customers as necessary
  • Acts as liaison with vendors that are part of the NOVA landscape; ex: DesCartes (Airline integration) Filebound (document management), MercuryGate (TMS), etc.
  • Establishes and maintains liaison relationship with business partners and IT organization in order to provide effective technical solutions.
  • May contribute to the business short-and long-term planning sessions and provides direction to ensure understanding of business goals and direction.
  • May provide assistance in business case development (i.e., research, data collection).
  • May investigate, resolve and escalate problems and develop recommendations for resolution.
  • Identifies need for technical assistance to help in problem resolution.
  • Keeps business partner(s) informed of problems, issues, and resolutions.
  • Collects application usage and performance metrics, analyzes and summarizes them, and publishes reports for stakeholder consumption when needed
  • Work in a fast paced environment with inbound tickets, and outbound communications to bring all tickets to resolution
  • Facilitate calls as needed for the business with updates based on the ongoing support and trends
  • Participates in the maintenance of support documents for consumption by other members of support teams, and provides support for the creation and maintenance of user documentation; ex: Knowledge Articles
  • Actively participates in defining processes, best practices, tools and standards for the NOVA team(s)
  • Be a part of various testing in QA/STAGE environments when tasked with replication of PROD issues
  • Contributes to the achievement of Cencora and World Courier organizational goals and objectives
  • Maintain all proper Corporate Training and Compliance testing
Desired Qualifications
  • Passion and enthusiasm for technology and emerging solutions
  • Must operate as an integral part of a team with appropriate transparency and commitment
  • Ability to self-direct is essential
  • Very strong business English communication skills, both verbal and written; Able to adjust and meet communication requirements depending on the audience and situation
  • Basic Microsoft Office skills; ex: Excel, Outlook, Word (Access is a plus)
  • Natural inclination towards good customer service including proactive engagement, "can-do" attitude and diligence in engagement and follow-up
  • Strong organizational skills with natural attention to detail
  • Comfortable working in a fluid, nimble, agile-based environment
  • Understanding of logistics and cargo routing
  • Knowledge and Experience with the MercuryGate TMS focus areas of Audit History, Audit Log, ConfigGroups, Dynamic Rule Sets (DRS), Large Code Tables (LCT), etc

Cencora provides global pharmaceutical distribution and a range of services, including specialty pharmacy, consulting, supply-chain management, patient support programs, and data analytics for healthcare providers, manufacturers, and veterinary practices. It works by combining physical drug distribution with value-added services such as inventory management, regulatory compliance guidance, patient support, and data-driven insights to optimize supply chains and outcomes. The company differentiates itself with an integrated, end-to-end offering that spans distribution, clinical services, analytics, and advisory support to help clients run more efficient operations and lower costs. Its goal is to improve healthcare outcomes by delivering comprehensive pharmaceutical solutions that enable better care and lower overall expenses.

Company Size

10,001+

Company Stage

IPO

Headquarters

Pennsylvania

Founded

1907

Simplify Jobs

Simplify's Take

What believers are saying

  • OneOncology $5B acquisition completed December 2025 boosts specialty oncology leadership.
  • EyeSouth retina business $1.1B deal expands Retina Consultants, accretive to EPS post-closure.
  • FY2026 EPS guidance raised to $17.65–$17.90 despite revenue headwinds from biosimilars.

What critics are saying

  • Frank R. Cruz investigation triggers shareholder lawsuits after May 6, 2026 Q2 revenue miss.
  • McKesson and Cardinal Health seize specialty drug share via aggressive GLP-1 pricing.
  • Inflation Reduction Act price cuts compress margins beyond $2B Q2 2026 headwind.

What makes Cencora unique

  • Cencora rebranded from AmerisourceBergen in August 2023, trading as COR on NYSE.
  • Cencora operates 1,400 locations across 50+ countries for global pharmaceutical distribution.
  • Cencora uniquely serves human and animal health with specialty pharmacy and MSO platforms.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Parental Leave

Adoption Assistance

Infertility Coverage

Family Planning Benefits

Behavioral Health Solutions

Professional Development Budget

Training Programs

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Mar 23rd, 2026
Cencora buys EyeSouth Partners' retina business for $1.1B to expand Retina Consultants of America

Cencora has signed a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion. The affiliated retina physicians will join Cencora's Retina Consultants of America, a leading management services organisation. The pharmaceutical solutions company expects the acquisition to be slightly accretive to its adjusted diluted earnings per share in the first twelve months following closure, net of financing costs. The transaction requires regulatory approvals and customary closing conditions. Cencora's reaffirmed fiscal 2026 financial guidance does not currently include the transaction closing within that fiscal year. BofA Securities served as lead financial advisor to Cencora, whilst Jefferies advised EyeSouth Partners, a portfolio company of Olympus Partners.

The Associated Press
Mar 17th, 2026
Cencora CFO James Cleary to retire after eight years, search underway for successor

Cencora has announced that Chief Financial Officer James F. Cleary will retire effective 30 June 2026. The pharmaceutical solutions company has engaged an executive search firm to identify potential successors from internal and external candidates. Cleary, 62, has served as CFO since November 2018 and joined Cencora in February 2015 following its acquisition of MWI Veterinary Supply, where he had been chief executive officer for over a decade. He will serve in an advisory capacity through the end of 2026 to ensure a smooth transition. Cencora reaffirmed its previously issued adjusted diluted earnings per share guidance range of $17.45 to $17.75 for fiscal year 2026. The company, ranked number 10 on the Fortune 500, generates more than $300 billion in annual revenue.

TradingView
Feb 11th, 2026
Cencora prices $3B senior notes offering across multiple maturities

Cencora has priced a $3 billion senior notes offering across various maturities, the company announced on 10 February 2026. No further details about the specific maturities, interest rates or intended use of proceeds were disclosed in the announcement.

Yahoo Finance
Feb 4th, 2026
Cencora raises fiscal 2026 guidance after completing OneOncology acquisition

Cencora reported 12% adjusted operating income growth and 9% adjusted diluted EPS growth in its fiscal 2026 first quarter, driven by its US healthcare solutions business. The company raised its full-year guidance to reflect year-over-year adjusted operating income growth of 11.5% to 13.5%. CEO Robert Mauch announced the completion of Cencora's acquisition of the majority remaining equity interest in OneOncology. The deal strengthens Cencora's specialty pharmaceutical leadership and MSO (management services organisation) platform. Cencora's strategy focuses on three priorities: strengthening leadership in specialty pharmaceuticals, partnering with market leaders, and enhancing patient access to pharmaceuticals. The company is leveraging technology and advanced analytics to improve customer experience and operational excellence whilst expanding its pharmaceutical-centric MSO footprint.

Yahoo Finance
Feb 4th, 2026
Cencora beats profit estimates on specialty drug demand, completes $5B OneOncology acquisition

Cencora beat Wall Street's first-quarter profit estimates on Wednesday, driven by sustained demand for specialty medicines and GLP-1 therapies. The drug distributor reported adjusted earnings of $4.08 per share, exceeding analysts' expectations of $4.04. The company completed its $5 billion acquisition of OneOncology from TPG in December, strengthening its presence in cancer care. It raised its fiscal 2026 adjusted operating income growth forecast to 11.5% to 13.5%, up from 8% to 10% previously. However, quarterly revenue of $85.93 billion fell short of expectations of $86.03 billion, sending shares down 5% in pre-market trading. Sales at its largest unit, US healthcare solutions, rose 5% year-over-year to $76.2 billion, boosted by prescription volumes of weight-loss drugs and specialty medicines.

INACTIVE